Wan, Y. C. E., Leung, T. C. S., Ding, D., Sun, X., Liu, J., Zhu, L., . . . Chan, K. M. (2020). Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes. Signal Transduct Target Ther.
Stile di citazione ChicagoWan, Yi Ching Esther, et al. "Cancer-associated Histone Mutation H2BG53D Disrupts DNA–histone Octamer Interaction and Promotes Oncogenic Phenotypes." Signal Transduct Target Ther 2020.
Citazione MLAWan, Yi Ching Esther, et al. "Cancer-associated Histone Mutation H2BG53D Disrupts DNA–histone Octamer Interaction and Promotes Oncogenic Phenotypes." Signal Transduct Target Ther 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.